• Contact IR
  • FAQS
  • Corporate Website
BioStem Technologies, Inc
Investor relations
  • Overview
  • News
  • Events & Presentations
    • Events
    • Latest Presentation
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Stock Info
  • Resources
    • Board of Directors
    • Management Team
    • Scientific Advisory Board
    • Analysts
    • Investor Email Alerts
  • Corporate Website
Select Page

Latest News

Investor Relations

Latest News

Select Year:
April 1, 2024 04:05 pm

BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase

March 21, 2024 08:00 am

BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024

February 26, 2024 10:39 am

PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market

January 30, 2024 04:05 pm

Amniowrap2(TM) Product Launch Leads Year of Highlights for BioStem Technologies

January 11, 2024 08:30 am

BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role

December 19, 2023 08:30 am

BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors

December 14, 2023 08:30 am

Center for Medicare Services Established National Pricing of AmnioWrap2(TM) in All MAC Regions

December 13, 2023 08:30 am

BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

November 13, 2023 05:17 pm

BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results

November 8, 2023 08:30 am

BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services

« Previous 1 … 3 4 5 6 7 … 9 Next »
  • Home
  • Our Science
  • Products
  • Resources
  • About Us
  • Contact Us
  • FAQS
  • CAREERS
  • TERMS AND CONDITIONS
  • PRIVACY POLICY
  • SHIPPING POLICY
  • REFUND POLICY
  • COOKIE POLICY
  • RSS
  • Instagram
  • X

© 2025 BioStem Technologies, Inc. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.

For screen reader problems with this website, please call (954) 380-8342 for assistance.

Disclaimer

You are about to review presentations, reports and/or filings of BioStem Technologies, Inc., that contain time-sensitive information. The information contained therein is only accurate as of the date thereof. BioStem Technologies, Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by BioStem Technologies, Inc.

I Accept I Decline